UBS O'Connor’s Integrated Wellness Acquisition Corp WEL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-121,140
Closed -$1.43M 605
2024
Q3
$1.43M Sell
121,140
-3,914
-3% -$45.8K 0.04% 231
2024
Q2
$1.45M Hold
125,054
0.04% 241
2024
Q1
$1.42M Hold
125,054
0.04% 239
2023
Q4
$1.4M Sell
125,054
-56,209
-31% -$622K 0.04% 229
2023
Q3
$1.99M Hold
181,263
0.04% 244
2023
Q2
$1.94M Sell
181,263
-4,086
-2% -$43.5K 0.04% 297
2023
Q1
$1.92M Hold
185,349
0.05% 321
2022
Q4
$1.91M Sell
185,349
-1,814
-1% -$18.5K 0.04% 474
2022
Q3
$1.89M Sell
187,163
-18,737
-9% -$188K 0.02% 641
2022
Q2
$2.05M Hold
205,900
0.02% 644
2022
Q1
$2.05M Buy
+205,900
New +$2.04M 0.02% 594

Other funds holding WEL

UBS O'Connor's WEL Position: Q4 2024 in Review

UBS O'Connor sold out of Integrated Wellness Acquisition Corp (WEL) in Q4 2024, closing a stake of 121,140 shares — an estimated $1.43M sold.

UBS O'Connor first reported a position in WEL in Q1 2022 and held it in 11 quarters. The position peaked at $2.05M in Q2 2022. 3 funds tracked by Wall St. Rank hold WEL as of Q4 2024.

  • UBS O'Connor reported no remaining Integrated Wellness Acquisition Corp position as of Q4 2024 after selling out during the quarter.
  • UBS O'Connor sold 121,140 Integrated Wellness Acquisition Corp shares in Q4 2024, an estimated $1.43M.
  • UBS O'Connor first reported a position in Integrated Wellness Acquisition Corp in Q1 2022 and held it in 11 quarters.
  • UBS O'Connor's Integrated Wellness Acquisition Corp position peaked at $2.05M in Q2 2022.
  • 3 funds tracked by Wall St. Rank held Integrated Wellness Acquisition Corp as of Q4 2024.

Based on UBS O'Connor's 13F filing for Q4 2024, filed 14 Feb 2025.